Medical costs and the drug industry
Schwartz, H.
Medical Times 109(3): 21s-24s; 28s
1981
ISSN/ISBN: 0025-7583 PMID: 7207081 Document Number: 173816
Document emailed within 1 workday
Related Documents
Eliasson, G.; Håkansson, J. 2001: Keep medical education independent! it should not be a scene of drug industry marketing Lakartidningen 98(39): 4168-4169Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
2012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Giri, J.C. 1986: The Indian medical profession and the Indian drug industry Journal of the Indian Medical Association 84(8): 254-255
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Mauch, R.P. 2001: Pharmaceutical industry and payer partnerships to manage costs and improve quality Managed Care 10(9 Suppl): 2-4; Discussion: 9-12
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Sloane, T. 2004: A study best forgotten. Moderating costs aren't good news for an industry in need of reform Modern healthcare 34(25): 20
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Kalinina, M.Iu.; Lagutina, G.N.; Spiridonov, V.L.; Kopylova, O.S. 2009: Evaluating quality of medical examinations of oil and gas industry workers in medical institutions Meditsina Truda i Promyshlennaia Ekologiia 2009(5): 9-14
Jensen, J.; Miklovic, N. 1985: High medical costs forcing patients to postpone seeking medical care Modern Healthcare 15(14): 209-210
Katon, W. 1996: Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs Journal of Clinical Psychiatry 57(Suppl 10): 11-18; Discussion: 19-22
Andreasen, J. 2003: Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities Ugeskrift for laeger 165(29): 2873-2876
Andersen, V. 1993: Drug costs Ugeskrift for Laeger 155(42): 3398-3399
Annertz, Mårten. 2004: Drug industry and bribes Lakartidningen 101(15-16): 1436
Hallager, K. 2004: Physicians and drug industry Ugeskrift for Laeger 166(21): 2069
Lexchin, J. 1989: Reducing drug costs New Zealand Medical Journal 102(872): 387
Samuels, A. 2018: Control of the cost of medicines and medical supplies to the NHS: Health Service and Medical Supplies (Costs) Act 2017 Medico-Legal Journal 86(1): 16-18
Pendleton, C. 2016: Transparency in drug industry relationships Nursing Times 112(21-23): 16